埃博拉疫苗的使用——全球范围,2021—2023年
本报告描述了2021—2023年期间埃博拉疫苗的使用情况及国际疫苗供应协调小组(ICG)管理的全球储备的作用。自2021年以来,ICG储备共运出145,690剂疫苗,其中139,120剂(95%)被转用于高风险人群的预防性接种,6,570剂(5%)用于疫情应对。在无埃博拉疫情时,可优先考虑将剂量转用于预防性接种,以预防传播并最大化储备的成本效益和收益。
要点
- 自2021年以来,ICG储备共运出145,690剂埃博拉疫苗。
- 其中139,120剂(95%)转用于高风险人群预防性接种,6,570剂(5%)用于疫情应对。
- 在无埃博拉疫情时,可优先考虑将剂量转用于预防性接种。
核心结论
- 在无埃博拉疫情时,可优先考虑将剂量转用于预防性接种,以预防传播并最大化储备的成本效益和收益。
研究设计与样本
- 本报告描述了2021—2023年期间埃博拉疫苗的使用情况及国际疫苗供应协调小组(ICG)管理的全球储备的作用。
主要发现
- 自2021年以来,ICG储备共运出145,690剂疫苗。
- 其中139,120剂(95%)转用于高风险人群的预防性接种,6,570剂(5%)用于疫情应对。
关键数值与推荐
- 免疫战略咨询专家组建议在埃博拉疫情期间使用1剂ERVEBO。
- 2021年建立了ERVEBO全球储备,以确保未来埃博拉疫情中公平、及时和有针对性地获取疫苗剂量。
临床怎么用
- 在无埃博拉疫情时,可优先考虑将剂量转用于预防性接种,以预防传播并最大化储备的成本效益和收益。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ebola virus disease (Ebola) is a rare but severe illness in humans, with an average case fatality rate of approximately 50%. Two licensed vaccines are currently available against Orthoebolavirus zairense, the virus that causes Ebola: the 1-dose rVSVΔG-ZEBOV-GP (ERVEBO [Merck]) and the 2-dose regimen of Ad26.ZEBOV and MVA-BN-Filo (Zabdeno/Mvabea [Johnson & Johnson]). The Strategic Advisory Group of Experts on Immunization recommends the use of 1-dose ERVEBO during Ebola outbreaks, and in 2021, a global stockpile of ERVEBO was established to ensure equitable, timely, and targeted access to vaccine doses for future Ebola outbreaks. This report describes the use of Ebola vaccines and the role of the stockpile developed and managed by the International Coordinating Group (ICG) on Vaccine Provision during 2021-2023. A total of 145,690 doses have been shipped from the ICG stockpile since 2021. However, because outbreaks since 2021 have been limited and rapidly contained, most doses (139,120; 95%) shipped from the ICG stockpile have been repurposed for preventive vaccination of high-risk groups, compared with 6,570 (5%) used for outbreak response. Repurposing doses for preventive vaccination could be prioritized in the absence of Ebola outbreaks to prevent transmission and maximize the cost-efficiency and benefits of the stockpile.
引用
- Kallay R, Doshi RH, Muhoza P, et al. Use of Ebola Vaccines - Worldwide, 2021-2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38662631. doi:10.15585/mmwr.mm7316a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。